Damon Runyon Research Foundation announces Clinical Investigator awards
June 19, 2012
The Damon Runyon Cancer Research Foundation recently announced the Spring 2012 winners of its Clinical Investigator Awards. Each of the six award winners will receive $450,000 over the course of three years to support innovative cancer research projects.
In addition, the foundation is supplying two previous award winners with two-year $300,000 continuation grants so they can further develop promising research. In total, the Clinical Investigator Award Committee approved $3.3 million in funding during the spring review.
This year's recipients include Holbrook E. Kohrt for work with monoclonal antibodies that target cancer cells and may ultimately serve as an alternative treatment to chemotherapy; Kevin B. Jones for his efforts to more effectively treat Synovial sarcoma, a cancer that targets young adults and adolescents and Oren J. Becher, for his research into Diffuse intrinsic pontine glioma, a brain cancer that often strikes children and does not respond to chemotherapy treatment.
The foundation seeks out young physician-scientists that are at the top of their fields for these awards, which are aimed to drive medical breakthroughs. Since 2000, The Damon Runyon Cancer Research Foundation have provided 64 such researchers with $41 million.
To encourage contributions, the organization guarantees 100 percent of donations will be put toward scientific research advancement. Other foundations and nonprofit organizations can take a similar stance, demonstrating the way funds are allocated with grant management software
, which can be used generate reports about accounts.